
Partnership started in April 2021 will continue to advance clinical trials through DCT solutions.
Partnership started in April 2021 will continue to advance clinical trials through DCT solutions.
Partnership will leverage Acclinate's NOWINCLUDED™ community through Trialbee Honey™ Omnichannel.
Addition of Complion's eReg offering adds another product to RealTime's site operations management system.
New center will focus on the clinical trials of clients who are developing cell and gene therapies across multiple therapeutic areas.
Functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience.
How streamlining relations between central labs and mobile health providers can get the most from hybrid and DCTs.
Designed with customer and patient feedback to expand options for eCOA and other DCT activities.
Study shows eCOA/ePRO interface is equivalent to responses from text-based smartphone formats.
Tufts CSDD report based on data collected and analyzed financial, personnel, and trend data from 18 top public and private CROs.
New pro-bono offering allows charities to access PHASTAR’s biometrics experts at no cost.
Recent investments bring clinical trial technology platform to the fore.
Nabil Chehab, medical affairs head of lung cancer franchise at AstraZeneca, discuss strategies used in the Phase III AEGEAN trial for treating non-small lung cancer (NSCLC).
eDiary to help patients with seizure disorders and their caregivers self-monitor and manage their seizures.
Represents major upgrade of cloud native, AI-enabled Intelligence platform.
As part of the partnership, MLHUMC has joined the global network of partner hospitals on Clinerion’s Patient Network Explorer platform.
Calyx Medical Imaging will extend Neosoma's AI-based neuro-oncology software device to its customers.
Multichannel platform offers tracking for multiple recruitment sources.
The business and people industry happenings of the last month, all in one place.
Payments technology will be complimented by transportation, two-way messaging, and participant feedback.
Companies will apply machine learning and natural language processing to curate text fields.
The Intrepid Partner Program aims to accelerate the optimization of patient safety and health measurements in both clinical research and post market clinical care.
Offering includes pre-configured modules for patient recruitment, eligibility screening, enrollment, data capture, and participant engagement.
Offering now includes GLP/GCP compliant molecular and cell biology testing.
New platform will enable analytics and pattern recognition use cases on RWD across Clinerion's Patient Network Explorer network.
Move will add new global talent to Cytel’s Strategic Consulting group.
Partnership to connect recruitment and enrollment systems.
Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste.
Enhancements will help community research sites offer more clinical trials by streamlining trial matching with pharma sponsors.
Next Generation Sequencing (NGS) initiative improved the accuracy and speed of identifying cancer mutations in solid tumors.